(Q73816008)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822100%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Induction of high level of specific antibody response to the neutralizing epitope ELDKWA on HIV-1 gp41 by peptide-vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822100%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

M Liao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822100%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Y Lu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822100%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Y Xiao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822100%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

M P Dierich

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822100%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Y Chen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822100%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822100%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

number of pages

6

1 reference

inferred from page(s)

published in

Peptides

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822100%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822100%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822100%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

463-468

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822100%20AND%20SRC:MED&resulttype=core&format=json

Core structure of gp41 from the HIV envelope glycoprotein

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900179-0

7 January 2021

Identification of a second site in HIV-1 gp41 mediating binding to cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900179-0

7 January 2021

The C domain of HIV-1 gp41 binds the putative cellular receptor protein P62

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900179-0

7 January 2021

Epitope vaccine: a new strategy against HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900179-0

7 January 2021

Capture of an early fusion-active conformation of HIV-1 gp41

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900179-0

7 January 2021

Association of antibody reactivity to ELDKWA, a glycoprotein 41 neutralization epitope, with disease progression in children perinatally infected with HIV type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900179-0

7 January 2021

A macromolecular multicomponent peptide vaccine prepared using the glutaraldehyde conjugation method with strong immunogenicity for HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900179-0

7 January 2021

Human immunodeficiency virus type 1 neutralizing antibodies accelerate clearance of cell-free virions from blood plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900179-0

7 January 2021

Fusion-competent vaccines: broad neutralization of primary isolates of HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900179-0

7 January 2021

Passively transferred antibodies directed against conserved regions of SIV envelope protect macaques from SIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900179-0

7 January 2021

Neutralizing antibodies in sera from macaques infected with chimeric simian-human immunodeficiency virus containing the envelope glycoproteins of either a laboratory-adapted variant or a primary isolate of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900179-0

7 January 2021

Back to primary school

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900179-0

7 January 2021

HIV-1 neutralizing antibodies: how full is the bottle?

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900179-0

7 January 2021

Restricted antigenic variability of the epitope recognized by the neutralizing gp41 antibody 2F5

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900179-0

7 January 2021

A broadly neutralizing human monoclonal antibody against gp41 of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900179-0

7 January 2021

Protection of macaques with a simian immunodeficiency virus envelope peptide vaccine based on conserved human immunodeficiency virus type 1 sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900179-0

7 January 2021

Development of a guinea pig model to assess immunogenicity of Haemophilus influenzae type b capsular polysaccharide conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2800%2900179-0

7 January 2021

10.1016/S0196-9781(00)00179-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10822100%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference